Skip to main content
2026 Spine Summit Main banner

    Minimally Invasive/Motion Preservation

    The Effect of Low Dose Ketorolac on Minimally Invasive Transforaminal Lumbar Interbody Fusion Patients: Final Analysis from a Randomized, Double-Blinded, Placebo-Controlled Trial

    Friday, February 27, 2026
    3:54 PM - 3:59 PM MST
    Disclosure(s):
    Bryce Sarcar, MD: No financial relationships to disclose